Meritza Rondon Kluge, OD - Medicare Optometrist in Lancaster, MA

Meritza Rondon Kluge, OD is a medicare enrolled "Optometrist" provider in Lancaster, Massachusetts. She graduated from medical school in 2009 and has 15 years of diverse experience with area of expertise as Optometry. She is a member of the group practice Lexington Eye Associates, Inc and her current practice location is 479 Old Union Tpke, Lancaster, Massachusetts. You can reach out to her office (for appointments etc.) via phone at (978) 537-3900.

Meritza Rondon Kluge is licensed to practice in Massachusetts (license number 4777) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1134450752.

Contact Information

Meritza Rondon Kluge, OD
479 Old Union Tpke,
Lancaster, MA 01523-3029
(978) 537-3900
(978) 537-6030



Healthcare Provider's Profile

Full NameMeritza Rondon Kluge
GenderFemale
SpecialityOptometry
Experience15 Years
Location479 Old Union Tpke, Lancaster, Massachusetts
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Meritza Rondon Kluge graduated from medical school in 2009
  NPI Data:
  • NPI Number: 1134450752
  • Provider Enumeration Date: 01/21/2010
  • Last Update Date: 01/09/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 6608901525
  • Enrollment ID: I20100317000887

Medical Identifiers

Medical identifiers for Meritza Rondon Kluge such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1134450752NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 4777 (Massachusetts)Primary
152W00000XOptometrist 1081 (New Hampshire)Secondary
152W00000XOptometrist OPC5146 (Florida)Secondary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Lexington Eye Associates, Inc569874898633

News Archive

WHO officials hope to eradicate polio by 2024

Shortly after the successful global Smallpox Eradication Programme (SEP) in the 80's, world leaders and public health officials announced a plan to eradicate poliomyelitis (polio) off the face of the Earth; the Pan American Health Organization and the World Health Organization (WHO) together championed the cause.

An effective Origami mask for COVID-19

A new study published on the preprint server medRxiv* in September 2020 reports constructing disposable masks using simple paper folding or origami steps, from filter material. This could make mask-wearing more acceptable and their construction less cumbersome.

Quantros introduces new External Comparative module for hospitals

Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, has introduced its new External Comparative module.

USPTO awards Alnylam Notice of Allowance for patent covering methods of inhibiting expression of mutant genes

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "John et al." patent (Application No. 10/384,463), which covers methods of inhibiting mutant genes with double-stranded RNAs from 19 to 30 nucleotides in length.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Meritza Rondon Kluge allows following entities to bill medicare on her behalf.
Provider NameD'ambrosio Eye Care Inc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1922020874
PECOS PAC ID: 5597755314
Enrollment ID: O20040514000021

News Archive

WHO officials hope to eradicate polio by 2024

Shortly after the successful global Smallpox Eradication Programme (SEP) in the 80's, world leaders and public health officials announced a plan to eradicate poliomyelitis (polio) off the face of the Earth; the Pan American Health Organization and the World Health Organization (WHO) together championed the cause.

An effective Origami mask for COVID-19

A new study published on the preprint server medRxiv* in September 2020 reports constructing disposable masks using simple paper folding or origami steps, from filter material. This could make mask-wearing more acceptable and their construction less cumbersome.

Quantros introduces new External Comparative module for hospitals

Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, has introduced its new External Comparative module.

USPTO awards Alnylam Notice of Allowance for patent covering methods of inhibiting expression of mutant genes

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "John et al." patent (Application No. 10/384,463), which covers methods of inhibiting mutant genes with double-stranded RNAs from 19 to 30 nucleotides in length.

Read more Medical News

› Verified 7 days ago

Provider NameLexington Eye Associates, Inc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1467502757
PECOS PAC ID: 5698748986
Enrollment ID: O20040816000511

News Archive

WHO officials hope to eradicate polio by 2024

Shortly after the successful global Smallpox Eradication Programme (SEP) in the 80's, world leaders and public health officials announced a plan to eradicate poliomyelitis (polio) off the face of the Earth; the Pan American Health Organization and the World Health Organization (WHO) together championed the cause.

An effective Origami mask for COVID-19

A new study published on the preprint server medRxiv* in September 2020 reports constructing disposable masks using simple paper folding or origami steps, from filter material. This could make mask-wearing more acceptable and their construction less cumbersome.

Quantros introduces new External Comparative module for hospitals

Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, has introduced its new External Comparative module.

USPTO awards Alnylam Notice of Allowance for patent covering methods of inhibiting expression of mutant genes

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "John et al." patent (Application No. 10/384,463), which covers methods of inhibiting mutant genes with double-stranded RNAs from 19 to 30 nucleotides in length.

Read more Medical News

› Verified 7 days ago

Provider NameBoston Laser Eye Institute Pc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1053496497
PECOS PAC ID: 9739123381
Enrollment ID: O20050614001090

News Archive

WHO officials hope to eradicate polio by 2024

Shortly after the successful global Smallpox Eradication Programme (SEP) in the 80's, world leaders and public health officials announced a plan to eradicate poliomyelitis (polio) off the face of the Earth; the Pan American Health Organization and the World Health Organization (WHO) together championed the cause.

An effective Origami mask for COVID-19

A new study published on the preprint server medRxiv* in September 2020 reports constructing disposable masks using simple paper folding or origami steps, from filter material. This could make mask-wearing more acceptable and their construction less cumbersome.

Quantros introduces new External Comparative module for hospitals

Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, has introduced its new External Comparative module.

USPTO awards Alnylam Notice of Allowance for patent covering methods of inhibiting expression of mutant genes

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "John et al." patent (Application No. 10/384,463), which covers methods of inhibiting mutant genes with double-stranded RNAs from 19 to 30 nucleotides in length.

Read more Medical News

› Verified 7 days ago

Provider NameLexington Eye Associates - Bid
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1801204714
PECOS PAC ID: 8820315682
Enrollment ID: O20150317000159

News Archive

WHO officials hope to eradicate polio by 2024

Shortly after the successful global Smallpox Eradication Programme (SEP) in the 80's, world leaders and public health officials announced a plan to eradicate poliomyelitis (polio) off the face of the Earth; the Pan American Health Organization and the World Health Organization (WHO) together championed the cause.

An effective Origami mask for COVID-19

A new study published on the preprint server medRxiv* in September 2020 reports constructing disposable masks using simple paper folding or origami steps, from filter material. This could make mask-wearing more acceptable and their construction less cumbersome.

Quantros introduces new External Comparative module for hospitals

Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, has introduced its new External Comparative module.

USPTO awards Alnylam Notice of Allowance for patent covering methods of inhibiting expression of mutant genes

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "John et al." patent (Application No. 10/384,463), which covers methods of inhibiting mutant genes with double-stranded RNAs from 19 to 30 nucleotides in length.

Read more Medical News

› Verified 7 days ago

Provider Name2020, Inc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1326460916
PECOS PAC ID: 4880947332
Enrollment ID: O20181030002087

News Archive

WHO officials hope to eradicate polio by 2024

Shortly after the successful global Smallpox Eradication Programme (SEP) in the 80's, world leaders and public health officials announced a plan to eradicate poliomyelitis (polio) off the face of the Earth; the Pan American Health Organization and the World Health Organization (WHO) together championed the cause.

An effective Origami mask for COVID-19

A new study published on the preprint server medRxiv* in September 2020 reports constructing disposable masks using simple paper folding or origami steps, from filter material. This could make mask-wearing more acceptable and their construction less cumbersome.

Quantros introduces new External Comparative module for hospitals

Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, has introduced its new External Comparative module.

USPTO awards Alnylam Notice of Allowance for patent covering methods of inhibiting expression of mutant genes

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "John et al." patent (Application No. 10/384,463), which covers methods of inhibiting mutant genes with double-stranded RNAs from 19 to 30 nucleotides in length.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Meritza Rondon Kluge is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Meritza Rondon Kluge, OD
479 Old Union Tpke,
Lancaster, MA 01523-3029

Ph: (978) 537-3900
Meritza Rondon Kluge, OD
479 Old Union Tpke,
Lancaster, MA 01523-3029

Ph: (978) 537-3900

News Archive

WHO officials hope to eradicate polio by 2024

Shortly after the successful global Smallpox Eradication Programme (SEP) in the 80's, world leaders and public health officials announced a plan to eradicate poliomyelitis (polio) off the face of the Earth; the Pan American Health Organization and the World Health Organization (WHO) together championed the cause.

An effective Origami mask for COVID-19

A new study published on the preprint server medRxiv* in September 2020 reports constructing disposable masks using simple paper folding or origami steps, from filter material. This could make mask-wearing more acceptable and their construction less cumbersome.

Quantros introduces new External Comparative module for hospitals

Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, has introduced its new External Comparative module.

USPTO awards Alnylam Notice of Allowance for patent covering methods of inhibiting expression of mutant genes

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "John et al." patent (Application No. 10/384,463), which covers methods of inhibiting mutant genes with double-stranded RNAs from 19 to 30 nucleotides in length.

Read more News

› Verified 7 days ago


Optometrist in Lancaster, MA

Judy Bavongkhoun, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 479 Old Union Tpke, Lancaster, MA 01523
Phone: 978-537-3900    Fax: 978-537-6030
Michael M Fu, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 479 Old Union Tpke, Lancaster, MA 01523
Phone: 978-537-3900    Fax: 978-537-6030
Dr. Kun Nancy Wu, OD
Optometrist
Medicare: May Accept Medicare Assignments
Practice Location: 479 Old Union Tpke, Lancaster, MA 01523
Phone: 978-537-3900    Fax: 978-537-6030
Dr. Khyla Eval Osaretin, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 479 Old Union Turnpike, Lancaster, MA 01523
Phone: 978-537-3900    Fax: 978-537-6030
Robin Sinn, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 479 Old Union Tpke, Lancaster, MA 01523
Phone: 978-537-3900    Fax: 978-537-6030
Dr. Ramkumar Ramamirtham, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 479 Old Union Tpke, Lancaster, MA 01523
Phone: 978-728-5445    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.